---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-217081"
form_type: "8-K"
ticker: "OVV"
cik: "0001792580"
company_name: "Ovintiv Inc."
filed_at: "2026-05-11T21:03:51+00:00"
generated_at: "2026-05-11T21:30:09.074024+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ovintiv Q1 net loss $630M on $1.2B impairment; Non-GAAP FCF $634M; net debt <$3.3B

## Summary
- Closed NuVista acquisition for ~$2.8B (~100 MBOE/d added) and Anadarko sale for ~$2.85B.
- Redeemed $700M 5.65% senior notes due 2028; annual interest savings ~$40M; net debt halved to <$3.3B.
- Q1 production 679 MBOE/d (225 Mbbls/d oil); Non-GAAP Cash Flow $1.2B; Free Cash Flow $634M.
- Year-to-date share buybacks $180M (3.2M shares); quarterly dividend $0.30/share declared.
- FY 2026 guidance: production 620-645 MBOE/d, capex $2.25-2.35B; Q2 guidance also provided.

## SEC filing metadata
- accession: 0001193125-26-217081
- form_type: 8-K
- ticker: OVV
- cik: 0001792580
- company_name: Ovintiv Inc.
- filed_at: 2026-05-11T21:03:51+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792580/000119312526217081/0001193125-26-217081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792580/000119312526217081/ovv-20260511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-217081
- JSON: https://secwatch.observer/filing/0001193125-26-217081.json
- Plain text: https://secwatch.observer/filing/0001193125-26-217081.txt

## Key facts
- Earnings Releases
  Ovintiv Inc. reported first quarter 2026 results: EPS $2.35 per share diluted. Guidance reaffirmed.
  - Period: first quarter 2026
  - EPS: $2.35 per share diluted
  - Guidance: reaffirmed
  - Result: reported results
  source text: Reported first quarter net loss of $630 million, or $2.35 per share diluted, including non-cash ceiling test impairments of $1.2 billion, after tax, or $4.30 per share diluted; impairment primarily driven by a weaker SEC 12-month trailing oil price relative to the previous quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792580/000119312526217081/0001193125-26-217081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.